Remove Pharmaceuticals Remove Small Molecule Remove Synthetic Chemistry Remove Trials
article thumbnail

Tackling pain and mental health with plant-based medicines

Drug Discovery World

Lastly, for treatment of substance use disorders, few pipeline drugs are currently undergoing clinical trials, yet those in trial only address the withdrawal symptoms but not the underlying reward circuitry and the cravings. Also, most second- generation antipsychotics have delayed onset, which may influence patient adherence.

article thumbnail

Global advances in synthetic biology

Drug Discovery World

It shows that the synthetic biology market was valued at US$9.5 According to SkyQuest Technology, the pharmaceutical industry is worth an estimated $2 trillion dollars and is expected to grow at 5% a year to 2025. These factors can significantly contribute to the growth of the synthetic biology market, it adds. .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AWS helps Pfizer accelerate drug development and clinical manufacturing

The Pharma Data

company (NASDAQ: AMZN), announced that it is working with Pfizer to create innovative, cloud-based solutions with the potential to improve how new medicines are developed, manufactured, and distributed for testing in clinical trials. (AWS), an Amazon.com, Inc.

article thumbnail

Drug Discovery and Medicinal Chemistry in the Era of Automation - Webinar Recap

The Strateos Blog: Drug Discovery

Director of Chemistry of Strateos gave an interactive talk focused on how automated robotics and integrated software are powering self-driving labs that are revolutionizing synthetic chemistry to support medicinal chemistry workflows. Director of R&D Strategy and Vince Yeh, Ph.D., " - Vince Yeh, Ph.D.,